| Product NDC: | 0555-0882 | 
| Proprietary Name: | HYDROXYUREA | 
| Non Proprietary Name: | Hydroxyurea | 
| Active Ingredient(s): | 500 mg/1 & nbsp; Hydroxyurea | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | CAPSULE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0555-0882 | 
| Labeler Name: | Barr Laboratories Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA075143 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 19981019 | 
| Package NDC: | 0555-0882-02 | 
| Package Description: | 100 CAPSULE in 1 BOTTLE (0555-0882-02) | 
| NDC Code | 0555-0882-02 | 
| Proprietary Name | HYDROXYUREA | 
| Package Description | 100 CAPSULE in 1 BOTTLE (0555-0882-02) | 
| Product NDC | 0555-0882 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Hydroxyurea | 
| Dosage Form Name | CAPSULE | 
| Route Name | ORAL | 
| Start Marketing Date | 19981019 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Barr Laboratories Inc. | 
| Substance Name | HYDROXYUREA | 
| Strength Number | 500 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Antimetabolite [EPC],Urea [Chemical/Ingredient] |